« Return to News | Ethics/Regulatory

Schulman Associates IRB acquires Independent IRB

Monday, December 5, 2011 11:18 AM

Schulman Associates Institutional Review Board has acquired Independent
Investigational Review Board. The transaction allows both organizations, which protect the rights of human research subjects, to provide a more comprehensive suite of review services for pharmaceutical, medical device, contract research organization and clinical research site customers.

"The strengths of the two organizations are remarkably complimentary," said Michael Woods, president and CEO of Schulman. "We are very excited by the added resources and capabilities Independent brings to the combined company."

With offices in Cincinnati, Ohio, and Plantation, Fla., the combined organization will provide research review services for a broad range of therapeutic areas and types of human subject research. Separately, each organization is accredited by Association for the Accreditation of Human
Research Protection Programs (AAHRPP), and each has a clean recent audit
history with FDA.

"Joining with Schulman allows Independent to provide the advantages of enhanced WebPortal and IT features to our established customer base," said Kim Lerner, outgoing CEO of Independent.

Anita McSharry, former president of Independent, added, "This is a perfect example of one plus one equaling far more than two. The benefits extend to every research site, sponsor and CRO that uses our services. The employees
of both companies also benefit from the additional resources that allow them to accomplish their mission to protect the rights of human research subjects more efficiently than ever."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.